Nuzenio

Coherus Oncology Inc

Coherus Oncology Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 20 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 00:32:08 GMTMaxim Group Maintains Coherus Oncology(CHRS.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Fri, 07 Aug 2026 19:09:08 GMTCHRS Maintained by Guggenheim -- Price Target Lowered to $10.00 - GuruFocus
Fri, 07 Aug 2026 17:19:00 GMTCoherus Oncology Price Target Cut to $10.00/Share From $12.00 by Guggenheim - Moomoo
Thu, 06 Aug 2026 12:30:00 GMTCoherus Oncology, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Thu, 06 Aug 2026 06:22:30 GMTCoherus Oncology Inc (CHRS) (Q2 2026) Earnings Call Highlights: - GuruFocus
Thu, 06 Aug 2026 04:02:00 GMTCoherus Oncology, Inc. 2026 Q2 10-Q Highlights: Financials, Risks, and Forward-Looking Statements for Investors - Minichart

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Coherus Oncology Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.